HXBM (HXBM) Stock Price & Analysis
HXBM (HXBM) rose 0.00% to USD 6.5 as of September 8, 2026 at 14:51 UTC, according to Nexqual real-time market data.
HXBM last closed at USD 6.5; the session ranged USD 6.5–6.5 on volume of 100 shares. Market capitalization is —, with a 52-week range of USD 1–6.5 (PNK). Source: Nexqual, September 8, 2026 at 14:51 UTC.
Key Statistics (as of September 8, 2026 at 14:51 UTC)
| Price | USD 6.5 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 6.5 |
| Open | USD 6.5 |
| Day Range | USD 6.5 – 6.5 |
| 52-Week Range | USD 1 – 6.5 |
| Volume | 100 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (HXBM)
Nexqual's technical model rates HXBM "BUY" based on 5 bullish and 3 bearish signals across 126 daily candles, as of September 8, 2026 at 14:51 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 95.48 (overbought) |
| vs SMA50 | Above (USD 1.98) |
| MACD | 1.14 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HMGN | HEMAGEN DIAGNOSTICS INC | USD 0 | ▲ 0% |
| MYMX | MYMETICS CORPORATION | USD 0 | ▲ 0% |
| ERGO | Entia Biosciences Inc. | USD 0 | ▲ 0% |
| ICCC | ImmuCell Corporation | USD 9.9 | ▼ 1.05% |
| INIS | Radnostix, Inc. | USD 0.05 | ▼ 10% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:51 UTC. This page is informational and not investment advice.